Non-alcoholic Fatty Liver Disease
"Non-alcoholic Fatty Liver Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Descriptor ID |
D065626
|
| MeSH Number(s) |
C06.552.241.519
|
| Concept/Terms |
Non-alcoholic Fatty Liver Disease- Non-alcoholic Fatty Liver Disease
- Non alcoholic Fatty Liver Disease
- NAFLD
- Nonalcoholic Fatty Liver Disease
- Fatty Liver, Nonalcoholic
- Fatty Livers, Nonalcoholic
- Liver, Nonalcoholic Fatty
- Livers, Nonalcoholic Fatty
- Nonalcoholic Fatty Liver
- Nonalcoholic Fatty Livers
Nonalcoholic Steatohepatitis- Nonalcoholic Steatohepatitis
- Nonalcoholic Steatohepatitides
- Steatohepatitides, Nonalcoholic
- Steatohepatitis, Nonalcoholic
|
Below are MeSH descriptors whose meaning is more general than "Non-alcoholic Fatty Liver Disease".
Below are MeSH descriptors whose meaning is more specific than "Non-alcoholic Fatty Liver Disease".
This graph shows the total number of publications written about "Non-alcoholic Fatty Liver Disease" by people in this website by year, and whether "Non-alcoholic Fatty Liver Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 3 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 4 | 3 | 7 |
| 2016 | 11 | 1 | 12 |
| 2017 | 132 | 19 | 151 |
| 2018 | 150 | 16 | 166 |
| 2019 | 57 | 6 | 63 |
| 2020 | 18 | 3 | 21 |
| 2021 | 6 | 1 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Non-alcoholic Fatty Liver Disease" by people in Profiles.
-
Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study. Eur J Gastroenterol Hepatol. 2021 12 01; 33(12):1578-1581.
-
Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
-
PNPLA3 and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system. Liver Int. 2021 11; 41(11):2801-2804.
-
Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH. Hepatology. 2021 10; 74(4):1825-1844.
-
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? J Formos Med Assoc. 2022 Feb; 121(2):454-466.
-
Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores. J Clin Lab Anal. 2021 Aug; 35(8):e23880.
-
Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease. Surg Obes Relat Dis. 2021 10; 17(10):1780-1786.
-
COVID-19 and pediatric fatty liver disease: Is there interplay? World J Gastroenterol. 2021 Jun 14; 27(22):3064-3072.
-
Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology. World J Gastroenterol. 2021 Jun 07; 27(21):2850-2870.
-
COVID-19 and the liver - Lessons learned. Liver Int. 2021 06; 41 Suppl 1:1-8.